Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Alnylam Pharmaceuticals Inc.
DescriptionRNAi therapeutic targeting complement 5 (C5)
Molecular Target Complement 5 (C5)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today